Monoclonal antibody therapy in cystic fibrosis and asthma

被引：1
作者：
Vu, Huy Duc [1 ]
Shafuddin, Eskandarain [1 ,2 ]
Willis, Jane [1 ]
Pallin, Michael [1 ]
Armstrong, David [1 ]
Daley, Christopher [1 ]
机构：
[1] Monash Med Ctr, Monash Lung Sleep Allergy & Immunol, Melbourne, Vic, Australia
[2] Waikato Hosp, Dept Resp Med, Hamilton, New Zealand
来源：
RESPIROLOGY | 2023年 / 28卷 / 06期
关键词：
asthma; cystic fibrosis; monoclonal antibodies; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; OMALIZUMAB;
D O I：
10.1111/resp.14498
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：571 / 574
页数：4
相关论文
共 14 条
  • [1] Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Ashkenazi, Moshe
    Sity, Saray
    Sarouk, Ifat
    El Bar Aluma, Bat
    Dagan, Adi
    Bezalel, Yael
    Bentur, Lea
    De Boeck, Kris
    Efrati, Ori
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2018, 11 : 101 - 107
  • [2] Asthma GIF., 2020, Global strategy for asthma management and prevention
  • [3] Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma
    Bourdin, Arnaud
    Shaw, Dominick
    Menzies-Gow, Andrew
    FitzGerald, J. Mark
    Bleecker, Eugene R.
    Busse, William W.
    Ferguson, Gary T.
    Brooks, Laura
    Barker, Peter
    Garcia Gil, Esther
    Martin, Ubaldo J.
    [J]. JOURNAL OF ASTHMA, 2021, 58 (04) : 514 - 522
  • [4] Mepolizumab use in cystic fibrosis-associated allergic bronchopulmonary aspergillosis
    Boyle, Maeve
    Mulrennan, Siobhain
    Morey, Sue
    Vekaria, Sona
    Popowicz, Natalia
    Tai, Anna
    [J]. RESPIROLOGY CASE REPORTS, 2021, 9 (01):
  • [5] Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
    Casale, Thomas B.
    Luskin, Allan T.
    Busse, William
    Zeiger, Robert S.
    Trzaskoma, Benjamin
    Yang, Ming
    Griffin, Noelle M.
    Chipps, Bradley E.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (01) : 156 - +
  • [6] Cystic Fibrosis Foundation Patient Registry, 2017 ANN DAT REP
  • [7] Anti-IL5 therapies for asthma
    Farne, Hugo A.
    Wilson, Amanda
    Powell, Colin
    Bax, Lynne
    Milan, Stephen J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
  • [8] A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis
    Habib, Al-Rahim R.
    Kajbafzadeh, Majid
    Desai, Sameer
    Yang, Connie L.
    Skolnik, Kate
    Quon, Bradley S.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis
    Koutsokera, Angela
    Corriveau, Sophie
    Sykes, Jenna
    Coriati, Adele
    Cortes, Daniel
    Vadas, Peter
    Chaparro, Cecilia
    McIntyre, Kieran
    Tullis, Elizabeth
    Stephenson, Anne L.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (01) : 119 - 124
  • [10] Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
    Kuruvilla, Merin E.
    Lee, F. Eun-Hyung
    Lee, Gerald B.
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2019, 56 (02) : 219 - 233
12